Fig. 2: Prognostic evaluation of the pan-cancer immunotherapy cohort.
From: Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
a Kaplan–Meier overall survival curves for the cohort, stratified by mRECIST response groups: complete response (CR), partial response (PR), stable disease (SD), and progressive disease (PD). b Kaplan–Meier progression-free survival curve for the cohort. c The concordance index for each dataset in the cohort, was calculated based on overall survival time. d Concordance index for each dataset in the cohort, was calculated based on progression-free survival time.
